Alcohol-Related Disorders Completed Phase 2 Trials for Melatonin (DB01065)

IndicationStatusPhase
DBCOND0027892 (Alcohol-Related Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03043443Melatonin Use for Sleep Problems in Alcohol Dependent PatientsTreatment